AR229103A1 - Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales - Google Patents
Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus salesInfo
- Publication number
- AR229103A1 AR229103A1 AR286818A AR28681881A AR229103A1 AR 229103 A1 AR229103 A1 AR 229103A1 AR 286818 A AR286818 A AR 286818A AR 28681881 A AR28681881 A AR 28681881A AR 229103 A1 AR229103 A1 AR 229103A1
- Authority
- AR
- Argentina
- Prior art keywords
- isotiazole
- aril
- derivatives
- salts
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/189,435 US4346094A (en) | 1980-09-22 | 1980-09-22 | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR229103A1 true AR229103A1 (es) | 1983-06-15 |
Family
ID=22697314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR286818A AR229103A1 (es) | 1980-09-22 | 1981-09-21 | Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4346094A (cs) |
| EP (1) | EP0048615B1 (cs) |
| JP (1) | JPS5785379A (cs) |
| KR (1) | KR830007597A (cs) |
| AR (1) | AR229103A1 (cs) |
| AT (1) | ATE7657T1 (cs) |
| AU (1) | AU7551681A (cs) |
| CS (1) | CS228536B2 (cs) |
| DD (1) | DD201790A5 (cs) |
| DE (1) | DE3163900D1 (cs) |
| DK (1) | DK417981A (cs) |
| ES (1) | ES8301225A1 (cs) |
| FI (1) | FI812940L (cs) |
| GB (1) | GB2084573B (cs) |
| GR (1) | GR75046B (cs) |
| IL (1) | IL63890A0 (cs) |
| NO (1) | NO813208L (cs) |
| PL (1) | PL130497B1 (cs) |
| PT (1) | PT73711B (cs) |
| RO (1) | RO82216A (cs) |
| YU (1) | YU227181A (cs) |
| ZA (1) | ZA816549B (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428956A (en) | 1980-12-29 | 1984-01-31 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4431652A (en) * | 1980-12-29 | 1984-02-14 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4539328A (en) * | 1983-03-25 | 1985-09-03 | Fmc Corporation | Nematicidal isothiazole derivatives |
| US4620865A (en) * | 1983-11-07 | 1986-11-04 | Eli Lilly And Company | Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides |
| IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
| ZW21687A1 (en) * | 1986-12-12 | 1988-07-20 | Hoffmann La Roche | Triazine derivatives |
| SG86971A1 (en) * | 1990-11-30 | 2002-03-19 | Teijin Ltd | 2-arylthiazole derivatives and pharmaceutical composition thereof |
| US5294630A (en) * | 1992-07-07 | 1994-03-15 | Eli Lilly And Company | Treatment of inflammatory bowel disease |
| US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
| MY117352A (en) * | 1995-10-31 | 2004-06-30 | Ciba Sc Holding Ag | Oximesulfonic acid esters and the use thereof as latent sulfonic acids. |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| EP1044002A4 (en) | 1997-11-07 | 2003-05-02 | Univ Johns Hopkins | METHODS FOR THE TREATMENT OF HEART CONTRACTILITY |
| TW575792B (en) * | 1998-08-19 | 2004-02-11 | Ciba Sc Holding Ag | New unsaturated oxime derivatives and the use thereof as latent acids |
| SG78412A1 (en) | 1999-03-31 | 2001-02-20 | Ciba Sc Holding Ag | Oxime derivatives and the use thereof as latent acids |
| KR20040089607A (ko) | 2002-02-06 | 2004-10-21 | 시바 스페셜티 케미칼스 홀딩 인크. | 설포네이트 유도체 및 잠산으로서의 이의 용도 |
| WO2006022374A1 (ja) * | 2004-08-27 | 2006-03-02 | Astellas Pharma Inc. | ２－フェニルピリジン誘導体 |
| US7612108B2 (en) * | 2004-08-27 | 2009-11-03 | Astellas Pharma Inc. | 2-phenylthiophene derivative |
| ES2355068T3 (es) | 2005-10-07 | 2011-03-22 | Astellas Pharma Inc. | Derivado del ácido triarilcarboxílico. |
| PT1992361E (pt) | 2006-02-24 | 2012-07-10 | Astellas Pharma Inc | Medicamento ou agente preventivo contra úlceras digestivas |
| GB2450975B (en) | 2007-07-12 | 2010-02-24 | Ciba Holding Inc | Yellow radiation curing inks |
| WO2009143020A1 (en) * | 2008-05-22 | 2009-11-26 | Bristol-Myers Squibb Company | Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same |
| DK2404908T3 (da) | 2009-02-27 | 2014-04-28 | Teijin Pharma Ltd | Fremgangsmåde til fremstilling af phenyl-substitueret heterocyclisk derivat gennem kobling under anvendelse af en overgangsmetalkatalysator |
| WO2010112408A1 (en) | 2009-03-30 | 2010-10-07 | Basf Se | Uv-dose indicator films |
| CN103068807B (zh) | 2010-08-27 | 2016-05-25 | 帝人制药株式会社 | 通过使用钯化合物的偶合法的苯基取代杂环衍生物的制备方法 |
| CN103443072B (zh) | 2011-01-28 | 2016-05-18 | 巴斯夫欧洲公司 | 包含肟磺酸酯作为热固化剂的可聚合组合物 |
| SI2980085T1 (en) * | 2013-03-29 | 2018-08-31 | Teijin Pharma Limited | Derivate pyrazole |
| US10487050B2 (en) | 2014-08-29 | 2019-11-26 | Basf Se | Oxime sulfonate derivatives |
| BR112017023057B1 (pt) | 2015-04-29 | 2023-03-28 | Bsn Medical Gmbh | Processo para preparação de no e processo cosmético |
| BR112017023170B1 (pt) | 2015-04-29 | 2022-08-16 | Bsn Medical Gmbh | Dispositivo de banho medicinal e seu uso |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1178604A (en) * | 1966-03-21 | 1970-01-21 | American Cyanamid Co | Novel Pyridinium Salts and Methods for Preparing Same |
| US3464999A (en) * | 1967-07-27 | 1969-09-02 | R & L Molecular Research Ltd | Thiadiazolylisothiazoles |
| GB1180268A (en) * | 1967-09-26 | 1970-02-04 | Ici Ltd | Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives |
| GB1192701A (en) * | 1968-03-22 | 1970-05-20 | Ici Ltd | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same |
| US3681498A (en) * | 1970-10-19 | 1972-08-01 | American Cyanamid Co | Isothiazolyl pyridinium salts as hypoglycemic agents |
-
1980
- 1980-09-22 US US06/189,435 patent/US4346094A/en not_active Expired - Lifetime
-
1981
- 1981-09-19 PL PL1981233103A patent/PL130497B1/pl unknown
- 1981-09-20 IL IL63890A patent/IL63890A0/xx unknown
- 1981-09-21 DE DE8181304325T patent/DE3163900D1/de not_active Expired
- 1981-09-21 RO RO81105346A patent/RO82216A/ro unknown
- 1981-09-21 AU AU75516/81A patent/AU7551681A/en not_active Abandoned
- 1981-09-21 PT PT73711A patent/PT73711B/pt unknown
- 1981-09-21 AR AR286818A patent/AR229103A1/es active
- 1981-09-21 NO NO813208A patent/NO813208L/no unknown
- 1981-09-21 DK DK417981A patent/DK417981A/da not_active Application Discontinuation
- 1981-09-21 EP EP81304325A patent/EP0048615B1/en not_active Expired
- 1981-09-21 AT AT81304325T patent/ATE7657T1/de not_active IP Right Cessation
- 1981-09-21 GR GR66108A patent/GR75046B/el unknown
- 1981-09-21 YU YU02271/81A patent/YU227181A/xx unknown
- 1981-09-21 FI FI812940A patent/FI812940L/fi not_active Application Discontinuation
- 1981-09-21 GB GB8128465A patent/GB2084573B/en not_active Expired
- 1981-09-21 ZA ZA816549A patent/ZA816549B/xx unknown
- 1981-09-21 ES ES505678A patent/ES8301225A1/es not_active Expired
- 1981-09-22 KR KR1019810003537A patent/KR830007597A/ko not_active Abandoned
- 1981-09-22 DD DD81233487A patent/DD201790A5/de unknown
- 1981-09-22 CS CS816978A patent/CS228536B2/cs unknown
- 1981-09-22 JP JP56150483A patent/JPS5785379A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RO82216A (ro) | 1983-07-07 |
| PL130497B1 (en) | 1984-08-31 |
| NO813208L (no) | 1982-03-23 |
| PL233103A1 (cs) | 1982-12-20 |
| GB2084573A (en) | 1982-04-15 |
| EP0048615B1 (en) | 1984-05-30 |
| CS228536B2 (en) | 1984-05-14 |
| JPS5785379A (en) | 1982-05-28 |
| FI812940A7 (fi) | 1982-03-23 |
| IL63890A0 (en) | 1981-12-31 |
| FI812940L (fi) | 1982-03-23 |
| DE3163900D1 (en) | 1984-07-05 |
| PT73711B (en) | 1982-12-20 |
| KR830007597A (ko) | 1983-11-04 |
| ATE7657T1 (de) | 1984-06-15 |
| US4346094A (en) | 1982-08-24 |
| GB2084573B (en) | 1984-09-12 |
| ES505678A0 (es) | 1982-12-01 |
| DK417981A (da) | 1982-03-23 |
| RO82216B (ro) | 1983-06-30 |
| ZA816549B (en) | 1983-04-27 |
| ES8301225A1 (es) | 1982-12-01 |
| PT73711A (en) | 1981-10-01 |
| YU227181A (en) | 1983-10-31 |
| EP0048615A1 (en) | 1982-03-31 |
| AU7551681A (en) | 1982-04-01 |
| GR75046B (cs) | 1984-07-12 |
| DD201790A5 (de) | 1983-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR229103A1 (es) | Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales | |
| AR228444A1 (es) | Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales | |
| AR240807A1 (es) | Procedimiento para obtener derivados de benzazepin-2-ona y sus sales | |
| ES487464A0 (es) | Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales | |
| AR228575A1 (es) | Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales | |
| AR222828A1 (es) | Procedimiento para la preparacion de 2,3,4,5-tetrahidro-6-feniltio-1h-3-benzazepinas y sus sales | |
| ES506222A0 (es) | Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales | |
| ES494668A0 (es) | Procedimiento para la preparacion de sales de la (+)-cate- quina | |
| ES502643A0 (es) | Procedimiento para la preparacion de compuestos de aril-fe- nil-acetileno y sus sales amonicas | |
| AR230280A1 (es) | Procedimiento para obtener derivados de carboestirilo y sus sales | |
| AR227882A1 (es) | Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales | |
| AR228144A1 (es) | Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales | |
| AR212468A1 (es) | Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales | |
| AR227906A1 (es) | Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina | |
| AR228586A1 (es) | Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables | |
| ES501535A0 (es) | Procedimiento para la preparacion de derivados de alquilfos-fonito | |
| ES493335A0 (es) | Procedimiento de preparacion de nuevos derivados ergol-8- enos y ergolinos y de sus sales de adicion acidas | |
| ES499729A0 (es) | Procedimiento para la preparacion de derivados de fenoxi- aminopropanol | |
| ES503407A0 (es) | Procedimiento para la preparacion de derivados de pirimidina | |
| ES543157A0 (es) | Procedimiento de preparacion de nuevos derivados de la 8-al-coxicarbonilaminoisoquinolina y de sus sales de adicion aci-da | |
| ES519853A0 (es) | Un procedimiento para la preparacion de derivados de anilinay sus sales. | |
| ES501736A0 (es) | Procedimiento para la preparacion de derivados de 2-guanidi-notiazol | |
| ES490315A0 (es) | Procedimiento de preparacion de nuevos derivados fenotiazi- nos o de sus sales de adicion acidas | |
| ES505576A0 (es) | Procedimiento para la preparacion de derivados de 7-oxopros-taciclina | |
| ES499356A0 (es) | Procedimiento para la preparacion de derivados de rifamicina |